Is It Too Late to Buy Novavax Stock?

09:37am, Thursday, 20'th Oct 2022
The company has been struggling lately.

Why Novavax Stock Couldn't Win on Wednesday

05:13pm, Wednesday, 19'th Oct 2022
FDA authorization isn't necessarily a slam dunk for a company.

What Is Going on With Novavax (NVAX) Stock Today?

02:16pm, Wednesday, 19'th Oct 2022
It's yet another down day in the markets right now, with most stocks feeling the pressure of bond yields which continue to creep higher. Accordingly, perhaps today's decline in Novavax (NASDAQ: NVAX
Novavax won Food and Drug Administration for its Covid booster on Wednesday, but NVAX stock dipped slightly in response. The post Why Novavax's Uphill Battle Continues Despite Winning U.S. Booster Aut
Shares of Novavax Inc. NVAX, +2.95% rallied 1.9% in morning trading Wednesday, after the biotechnology company said its protein-based COVID-19 vaccine booster was granted emergency use authorization (
The U.S. Food and Drug Administration on Wednesday authorized Novavax Inc's COVID-19 vaccine as a booster for adults.
Novavax's Covid shots rely on protein technology used in other vaccines for decades, rather than the messenger RNA used in the Pfizer and Moderna vaccines.

More Likely to Double First: Teladoc or Novavax?

06:00am, Wednesday, 19'th Oct 2022
Both stocks soared during the early days of the pandemic.

Got $300? 3 Genius Stocks to Buy on the Dip

05:21am, Tuesday, 18'th Oct 2022
You don't need a boatload of cash to begin building wealth on Wall Street.
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
These four tech stocks are down nearly 90%.

Why Novavax Stock Had an Ugly Friday

06:55pm, Friday, 14'th Oct 2022
Investors ding the biotech's shares one day after it reported quite good news about an experimental vaccine.
Novavax (NVAX) reports positive data from its phase I/II study evaluating a combination of its COVID-19 and the seasonal influenza vaccine.

Why Novavax Stock Is Skyrocketing This Week

03:48pm, Thursday, 13'th Oct 2022
The vaccine maker had a flurry of good news.
Shares of Novavax Inc. NVAX, +6.69% were down 3.4% in premarket trading on Thursday after the company said its combination COVID-19 vaccine and flu shot candidate generated an immune response in a Pha
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE